Role of microRNAs in arrhythmogenic cardiomyopathy: translation as biomarkers into clinical practice-Reference-Cited by-同舟云学术

Role of microRNAs in arrhythmogenic cardiomyopathy: translation as biomarkers into clinical practice

Published:2023-09 Issue: Volume:259 Page:72-82
ISSN:1931-5244
Container-title:Translational Research
language:en
Short-container-title:Translational Research

Author:

Alcalde Mireia,Toro Rocío,Bonet Fernando,Córdoba-Caballero José,Martínez-Barrios Estefanía,Ranea Juan Antonio,Vallverdú-Prats Marta,Brugada Ramon,Meraviglia Viviana,Bellin Milena,Sarquella-Brugada Georgia,Campuzano Oscar^ORCID

Publisher

Elsevier BV

Subject

Biochemistry (medical),Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)

Reference106 articles.

1. Fibro-fatty remodelling in arrhythmogenic cardiomyopathy;Kohela;Basic Res Cardiol,2022

2. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases;Wilde;Heart Rhythm,2022

3. Update on the diagnostic pitfalls of autopsy and post-mortem genetic testing in cardiomyopathies;Grassi;Int J Mol Sci,2021

4. Causes of sudden cardiac death in young athletes and non-athletes: systematic review and meta-analysis: sudden cardiac death in the young;D'Ascenzi;Trends Cardiovasc Med,2022

5. Arrhythmogenic right ventricular cardiomyopathy;Krahn;JACC Clin Electrophysiol,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNAs in Heart Development and Disease;International Journal of Molecular Sciences;2024-01-30